Clinical Trial Update: PERCI- Medium Cut Off (MCO) [NA]

View source ↗

Summary

A completed clinical trial of PERCI Medium Cut Off (MCO) related to chronic kidney disease and chronic inflammatory conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Inflammatory Disease

Snippet

Sponsor: Vantive Health LLC | Conditions: Chronic Kidney Failure, Chronic Inflammation | NA | Status: COMPLETED